Medios AG (OTCMKTS:MEDOF) Sees Significant Decline in Short Interest

Medios AG (OTCMKTS:MEDOF) was the target of a significant drop in short interest in the month of May. As of May 29th, there was short interest totaling 694 shares, a drop of 63.9% from the May 14th total of 1,924 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ? days.

Medios Price Performance

MEDOF remained flat at C$13.64 during trading on Friday. Medios has a 12 month low of C$13.64 and a 12 month high of C$13.64. The business’s fifty day moving average is C$13.64 and its two-hundred day moving average is C$13.64.

About Medios

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, parenteral nutrition solutions, and investigational medicinal products.